oxprenolol has been researched along with procainamide in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Januskevicius, ZI; Zabela, PV; Zemaityte, DI | 1 |
| Platek, H | 1 |
| Correia, MJ; d'Almeida, VC; da Costa, FL; Mourão, L; Ribeiro, C; Tuna, JL | 1 |
1 review(s) available for oxprenolol and procainamide
| Article | Year |
|---|---|
[Anti-arrhythmic drugs].
Topics: Ajmaline; Anti-Arrhythmia Agents; Bretylium Compounds; Catecholamines; Cell Membrane Permeability; Digitalis Glycosides; Heart Atria; Heart Ventricles; Humans; Oxprenolol; Phenytoin; Procainamide; Quinidine | 1973 |
1 trial(s) available for oxprenolol and procainamide
| Article | Year |
|---|---|
Procainamide, oxprenolol and amiodarone as antidysrhythmic drugs in myocardial infarction.
Topics: Amiodarone; Benzofurans; Cardiac Complexes, Premature; Clinical Trials as Topic; Death, Sudden; Double-Blind Method; Humans; Myocardial Infarction; Oxprenolol; Procainamide; Random Allocation | 1980 |
7 other study(ies) available for oxprenolol and procainamide
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
[Various aspects of individualization of drug therapy of extrasystole].
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Atropine; Belladonna Alkaloids; Cardiac Complexes, Premature; Drug Evaluation; Drug Therapy, Combination; Humans; Injections, Intravenous; Middle Aged; Oxprenolol; Potassium Magnesium Aspartate; Procainamide; Propranolol; Quinidine; Strophanthins; Verapamil | 1977 |